A simple urine tests could help diagnose a serious pregnancy disorder suffered by millions of women including Kim Kardashian, Mariah Carey and Sophie Ellis Bextor.

    Pre-eclampsia occurs during the second half of pregnancy and is characterised by high blood pressure and a rise in the normal level of a protein in the urine, called proteinuria.

    The disorder affects one in 10 pregnancies in the UK and women who develop it can experience swelling of the feet, ankles, face and hands, along with severe headaches and vision problems.

    The condition puts the health and life of an expectant mother and her baby at serious risk.

    Doctors often have to strike a balance between delivering babies late enough to survive and early enough to avoid complications from the condition.

    Pre-eclampsia is attributable for up to one in five pre-term births and affects around one in 10 pregnancies in the UK.

    A major issue with the condition is that its symptoms are so ambiguous, that doctors rarely diagnose ‘pure’ pre-eclampsia.

    However, even if a diagnosis is made, it is still not possible to identify what has caused the disorder, so it is difficult to control effectively.

    In the new study, published in the Journal of Proteomics, researchers sought to identify potential biomarkers for the condition.

    They now hope that in the future, women will be able to receive an accurate and early diagnosis through a non-invasive urine test.

    Researchers focussed on protein in urine, which significantly increases ten times above the normal 0.03g/l level in pre-elcampsia sufferers.

    The scientists sought to find out whether the peptides, or pieces of proteins, could carry information about the disease.

    To identify the potential biomarkers, the researchers compared urine samples of three groups of ten women: women with severe pre-elcampsia; mild pre-eclampsia and women without the disorder.

    After studying the samples, the team identified 35 potential peptide biomarkers for pre-eclampsia.

    These included fragments of alpha-1-antitrypsin, collagen alpha-1(I) and alpha-1(III) chains and uromodulin.

    Author Professor Evgeniy Nikolaev, from the Moscow Institute of Physics and Technology, said: “We were able to confirm a number of markers previously proposed by our colleagues abroad, and also identify some new ones.

    “We will obviously need to verify and confirm their significance.

    “What is important is that this non-invasive method has proven effective – it can be used as a basis to develop a clinical method.”


      • After working as a news and celebrity journalist in the uber-glamorous Los Angeles with Pacific Coast News, our deputy news editor Paul has returned to News Today where he is a deputy news editor. Also working at SWNS, Paul runs a team of hard-working reporters that span the length and breadth of the UK.

        • Show Comments (0)

        Your email address will not be published. Required fields are marked *

        comment *

        • name *

        • email *

        • website *

        This site uses Akismet to reduce spam. Learn how your comment data is processed.


        You May Also Like

        Burger King® Resturaunts launch new Christmas menu & packaging

        LONDON, 18th November 2015 – Today, BURGER KING® brand announces it will roll out ...

        Pregnant women with whose blood pressure is even slightly raised can be dramatically more at risk of developing diabetes or heart disease, say scientists. In the first study of its kind a condition called pre-hypertension - where blood pressure is in the upper range of normal - has been shown to be potentially dangerous. Up to one-in-seven expectant mothers in the UK already suffer high blood pressure and the discovery could lead to many more requiring monitoring. Professor Jian-Min Niu, of Guangdong Women and Children Hospital in China, said: "Our findings underscore an important issue that has been long ignored in clinical practice - the fact criteria for hypertension in pregnancy are derived from the general population. "We anticipate if reaffirmed in further research, our study could spark a change in what we currently deem healthy blood pressure in pregnant women." The research found pregnant women whose blood pressure is in the upper ranges of normal could be at high risk of developing metabolic syndrome - a combination of diabetes, hypertension and obesity - and heart disease risk after giving birth. Current guidelines do not distinguish between pregnant women and the general population and define hypertension as persistently elevated blood pressure that is 140 millimeters of mercury (mm Hg) systolic or 90 mm Hg diastolic and above. Readings of 120-139 mm Hg systolic over 80-89 mm Hg diastolic is deemed 'pre-hypertension' - a warning sign of high blood pressure in the future. But the study published in Hypertension said pregnant women with blood pressure in this range had 6.5 times greater odds of developing metabolic syndrome compared to those in the lower normal range. It looked at 507 Chinese women with uncomplicated pregnancies, no history of hypertension and normal blood sugar and cholesterol who underwent seven or more blood pressure measurements along with other standard tests including weight measurements and foetal ultrasounds. Blood sugar and cholesterol levels were also tested at the start, shortly before and after giving birth and once every few months for up to 1.6 years after giving birth. The participants were grouped into three categories including those whose blood pressure remained on the lower end of normal (34%), around the mid-point (52%) or in the pre-hypertension range (13%). A series of snapshot measurements did not predict future risk but patterns of repeated elevations did - highlighting the dynamic nature of blood pressure during pregnancy. The results support the idea of pregnancy as a cardiovascular stress test for women that can reveal underlying disturbances in blood pressure regulation, glucose and cholesterol metabolism. Abnormalities in all three areas can disrupt functions and lead to full-blown cardiovascular disease years down the road. Prof Niu said globally the burden of cardio-metabolic diseases in women has been rising steadily over the last decades. He said: "Blood pressure measurements are already done as matter of routine and cost-effective checkups during pregnancy so our findings underscore this tool's potential to gauge a woman's post-partum cardiovascular risk. "Early identification of metabolic risk factors and implementation of lifestyle modifications may help delay the onset of cardiovascular disease that would present itself 20 to 30 years after delivery."


        Pregnant women with whose blood pressure is even slightly raised can be dramatically more ...



        Chelsea star John Terry has offered to pay for the funeral of his biggest ...